Hjem › Alvorlig depressiv lidelse › Pennsylvania
Alvorlig depressiv lidelse kliniske forsøg i Pennsylvania
27 studier for Alvorlig depressiv lidelse søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07775300Precision Depression Adalimumab Trial
- University of Pennsylvania, Philadelphia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07845604Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- University of Pennsylvania, Philadelphia
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 25. sep. 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Allentown
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 14. sep. 2026 · NCT07065240Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
- University of Pennsylvania, Philadelphia
RekruttererTidlig fase 1
Alder 25 til 65 · Alle køn · Opdateret 10. sep. 2026 · NCT06788249Decoding and Modulating Affective Brain States
- University of Pennsylvania, Philadelphia
RekruttererNævner betaling til deltagere
Alder 18 til 65 · Alle køn · Opdateret 3. sep. 2026 · NCT05437705A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Allentown
- Draig Clinical Site, Media
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Pennsylvania Hospital, Philadelphia
Rekrutterer
Alder 22 til 70 · Alle køn · Opdateret 28. aug. 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Media
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 26. aug. 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Philadelphia, Philadelphia
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 10. aug. 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Suburban Research Associates, Media
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 6. aug. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Lehigh Center For Clinical Research, Allentown
- Adams Clinical - Philadelphia, Philadelphia
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 3. aug. 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
- Adams Clinical, Philadelphia
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 27. jul. 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments
- Bellefield Towers, Pittsburgh
Rekrutterer
Alder 18 til 55 · Alle køn · Opdateret 22. maj 2026 · NCT06976840Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Philadelphia, Philadelphia
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 20. maj 2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Scranton Medical Institute, LLC, Moosic
- University of Pennsylvania, Philadelphia
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. maj 2026 · NCT06524830Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
- University of Pittsburgh, Pittsburgh
Rekrutterer
Alder 18 til 55 · Alle køn · Opdateret 4. mar. 2026 · NCT05703256Taking Action for College Students
- Temple University, Philadelphia
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. dec. 2025 · NCT06700902Neurofeedback to Treat Depression - 2
- Center for Neuromodulation in Depression and Stress, Philadelphia
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 4. dec. 2025 · NCT07159061Study of ALTO-300 in MDD
- Site 216, Allentown
- Site 350, Media
- Site 352, Moosic
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 24. jul. 2025 · NCT05922878Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.